These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 16892733

  • 41. [Treatment of microcytic carcinoma of the lung with vincristine, adriamycin, cyclophosphamide and VP-16].
    Sangro Gómez-Acebo B, Díaz-Rubio García E, Martín Jiménez M, González Larriba JL, Vila Borrajo C.
    Rev Clin Esp; 1986 Oct; 179(6):296-301. PubMed ID: 3025943
    [No Abstract] [Full Text] [Related]

  • 42. Intensive induction treatment of small cell bronchogenic carcinoma with cyclophosphamide, methotrexate, and etoposide.
    Bonomi P, O'Reilly W, Vogl SE, Ruckdeschel JC, Stolbach L, Bunting N, Creech RH.
    Cancer Treat Rep; 1985 Sep; 69(9):1007-9. PubMed ID: 2992783
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. [Immunohistochemical study and treatment result of small cell lung carcinoma using combination chemotherapy].
    Mei QD, Yan M, Huang XL.
    Zhonghua Zhong Liu Za Zhi; 1994 Jan; 16(1):43-6. PubMed ID: 8033748
    [Abstract] [Full Text] [Related]

  • 45. [Adriamycin in the combined chemotherapy of small-cell lung cancer].
    Perevodchikova NI, Bychkov MB, Ausekar BV.
    Antibiotiki; 1983 Aug; 28(8):628-32. PubMed ID: 6314882
    [Abstract] [Full Text] [Related]

  • 46. Pulmonary blastoma: remission with chemotherapy.
    Nissen MH, Jacobsen M, Vindeløv L, Olsen J, Rørth M.
    Eur J Respir Dis; 1984 Jul; 65(5):377-9. PubMed ID: 6086368
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Do the time to chemotherapy response and the dose intensity have an impact on patient outcome in advanced non-small cell lung cancer?
    Radosavljevic D, Golubicic I, Gavrilovic D, Kezic I, Jelic S.
    J BUON; 2009 Jul; 14(2):203-9. PubMed ID: 19650167
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. CCNU, vincristine, methotrexate, and procarbazine treatment of relapsed small cell lung carcinoma.
    Poplin EA, Aisner J, Van Echo DA, Whitacre M, Wiernik PH.
    Cancer Treat Rep; 1982 Jul; 66(7):1557-9. PubMed ID: 6284360
    [Abstract] [Full Text] [Related]

  • 51. [Dose-effect of chemotherapy in bronchial small-cell cancer].
    de Crevoisier R, le Cesne A, le Chevalier T.
    Rev Mal Respir; 1997 Sep; 14(4):269-75. PubMed ID: 9411610
    [Abstract] [Full Text] [Related]

  • 52. Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study.
    Rusu P, Ciuleanu TE, Cernea D, Pelau D, Gaal V, Cebotaru C, Guttman T, Todor N, Ghilezan N.
    J BUON; 2007 Sep; 12(1):33-9. PubMed ID: 17436399
    [Abstract] [Full Text] [Related]

  • 53. Combination chemotherapy in metastatic or recurrent non-small cell bronchogenic carcinoma. 5-year results.
    Ojala A, Nikkanen VN, Paloheimo S, Palojoki A, Thölix E.
    Strahlentherapie; 1983 Dec; 159(12):775-7. PubMed ID: 6364459
    [Abstract] [Full Text] [Related]

  • 54. Preoperative chemotherapy is essential for conservative surgery of Askin tumors.
    Veronesi G, Spaggiari L, De Pas T, Solli PG, De Braud F, Catalano GP, Curigliano G, Leo F, Pastorino U.
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):428-9. PubMed ID: 12579122
    [No Abstract] [Full Text] [Related]

  • 55. [Chemotherapy of lung cancer].
    Dement'eva NP.
    Sov Med; 1984 Feb; (11):55-61. PubMed ID: 6084308
    [No Abstract] [Full Text] [Related]

  • 56. [Phase II study with etoposide/vincristine in small cell bronchial cancer (extensive disease)].
    von Pawel J, Wilke H, Vallée D, Dimbeck H, Schmoll HJ.
    Pneumologie; 1990 Feb; 44 Suppl 1():582-3. PubMed ID: 1695002
    [Abstract] [Full Text] [Related]

  • 57. [Polychemotherapy using methotrexate, adriamycin, cyclophosphamide and CCNU (MACC) in patients with advanced adenocarcinoma and large cell carcinoma of the lung].
    Karnicka-Młodkowska H, Jassem J, Mierzewski P, Słupek A, Mierzwa W, Decker E, Prokop A, Krawczyk K, Kowal E, Firlik M.
    Pneumonol Pol; 1986 Dec; 54(12):546-51. PubMed ID: 3035511
    [No Abstract] [Full Text] [Related]

  • 58. [Several years of follow-up and results of chemotherapy of small cell bronchial carcinoma].
    Gatzemeier U.
    Prax Klin Pneumol; 1983 Apr; 37(4):144-7. PubMed ID: 6306636
    [No Abstract] [Full Text] [Related]

  • 59. A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer.
    Altinbas M, Coskun HS, Er O, Ozkan M, Eser B, Unal A, Cetin M, Soyuer S.
    J Thromb Haemost; 2004 Aug; 2(8):1266-71. PubMed ID: 15304029
    [Abstract] [Full Text] [Related]

  • 60. [Combination chemotherapy with VP-16 in the treatment of lung cancer and malignant lymphoma].
    Hosomi Y, Shibuya M.
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1352-6. PubMed ID: 11681241
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.